These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3953366)

  • 21. Renal effects of manidipine hydrochloride. A new calcium antagonist in hypertensive patients.
    Takabatake T; Ohta H; Sasaki T; Satoh S; Ohta K; Ise T; Kobayashi K
    Eur J Clin Pharmacol; 1993; 45(4):321-5. PubMed ID: 8299663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First-step treatment of mild to moderate uncomplicated essential hypertension by a new calcium antagonist: nicardipine.
    Bellet M; Loria Y; Lallemand A
    J Cardiovasc Pharmacol; 1985; 7(6):1149-53. PubMed ID: 2418302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of nicardipine or nifedipine added to propranolol in patients with coronary artery disease.
    Pouleur H; Etienne J; Van Mechelen H; Van Eyll C; Charlier AA; Brasseur LA; Rousseau MF
    Postgrad Med J; 1984; 60 Suppl 4():23-8. PubMed ID: 6527976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of calcium entry blockers on renin-angiotensin-aldosterone system, renal function and hemodynamics, salt and water excretion and body fluid composition.
    Bauer JH; Sunderrajan S; Reams G
    Am J Cardiol; 1985 Dec; 56(16):62H-67H. PubMed ID: 2933950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the renal effects of dilevalol and carteolol in patients with mild to moderate essential hypertension.
    Baba T; Murabayashi S; Tomiyama T; Takebe K
    Eur J Clin Pharmacol; 1990; 38(3):305-7. PubMed ID: 2187701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the efficacy of nicardipine, a new calcium channel blocker, with nifedipine in the treatment of mild to moderate essential hypertension.
    Armstrong C; Garnham J; Blackwood R
    Postgrad Med J; 1987 Jun; 63(740):463-6. PubMed ID: 3432173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of cilnidipine on renal function in SHR and endothelin-induced renal dysfunction].
    Dozen M; Watanabe K; Hosono M; Hayashi Y
    Nihon Yakurigaku Zasshi; 1996 Feb; 107(2):79-89. PubMed ID: 8721010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of dihydropyridine Ca blockers on the renal function in nephrotic spontaneously hypertensive rat (SHR).
    Oizumi K; Miyamoto M; Koike H
    Biol Pharm Bull; 1994 Mar; 17(3):407-10. PubMed ID: 8019507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitrendipine reverses vasoconstriction and renal hemodynamic changes in experimental hypertension.
    Sterzel RB; Huelsemann JL; McKenzie DE; Wilcox CS
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1024-7. PubMed ID: 6085360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of nicardipine in a hypertensive patient with diabetes mellitus.
    Sakata S; Miura K
    Clin Ther; 1984; 6(5):600-2. PubMed ID: 6478468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracellular Ca++ antagonist, HA1004: pharmacological properties different from those of nicardipine.
    Asano T; Hidaka H
    J Pharmacol Exp Ther; 1985 May; 233(2):454-8. PubMed ID: 3999029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Divergent natriuretic action of calcium channel antagonists in mongrel dogs: renal haemodynamics as a determinant of natriuresis.
    Honda M; Hayashi K; Matsuda H; Kubota E; Tokuyama H; Okubo K; Ozawa Y; Saruta T
    Clin Sci (Lond); 2001 Oct; 101(4):421-7. PubMed ID: 11566080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal effects of nicardipine in essential hypertension: differences between acute and chronic therapy.
    Smith SA; Rafiqi EI; Gardener EG; Young MA; Littler WA
    J Hypertens; 1987 Dec; 5(6):693-7. PubMed ID: 3429869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronary and systemic hemodynamic effects of nicardipine.
    Lambert CR; Hill JA; Nichols WW; Feldman RL; Pepine CJ
    Am J Cardiol; 1985 Mar; 55(6):652-6. PubMed ID: 3976506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of nifedipine on renal function in patients with essential hypertension.
    Reams GP; Hamory A; Lau A; Bauer JH
    Hypertension; 1988 May; 11(5):452-6. PubMed ID: 3366479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic effects of a dihydropyridine calcium antagonist, NB-818 (NPK-1886) in anesthetized dogs.
    Nishikibe M; Nagura J; Kamei K; Fukuroda T
    Arch Int Pharmacodyn Ther; 1988; 291():7-20. PubMed ID: 3365068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of angiotensin converting enzyme inhibitor and calcium channel blocker on renal function of spontaneously hypertensive rat].
    Endo M
    Nihon Jinzo Gakkai Shi; 1991 Nov; 33(11):1161-72. PubMed ID: 1808367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the calcium antagonist manidipine on renal hemodynamics and function in dogs: comparison with nifedipine.
    He H; Tamaki T; Aki Y; Kiyomoto H; Iwao H; Miyatake A; Abe Y
    Blood Press Suppl; 1992; 3():68-74. PubMed ID: 1343294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immediate and longer-term effects of nicardipine, at rest and during exercise, in patients with coronary artery disease.
    Visser CA; Jaarsma W; Kan G; Lie KI
    Postgrad Med J; 1984; 60 Suppl 4():17-20. PubMed ID: 6527974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal effects of acute and long-term treatment with felodipine in essential hypertension.
    Hulthén UL; Katzman PL
    J Hypertens; 1988 Mar; 6(3):231-7. PubMed ID: 3361121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.